Publication: 4420

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
      QxMD      Google Scholar   
Citation:
Lancet Oncol vol 22 (8) 1139-1150
Year:
2021
Type:
Manuscript
Funding:
Not Funded
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                                                                                                                                                                                         
Networks:
 
Study
Alliance-A151733
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N9831
Phases:
N/A, 3
Keywords: